Skip to content

Financing growth without depending on the market cycle

Volatile markets, geopolitical shifts, regulatory change and the cost of raising capital to grow: for most companies, these set the pace of growth from outside. Public funding is the one financing component you can plan for. It preserves your own capital, underpins investment and makes strategic projects less dependent on short-term conditions. More of your strategy stays on your own timeline.

Heineken
UltiMaker
Coolblue
ABN AMRO
KPN
Vattenfall
PostNL
ProRail
NS
Jumbo
ANWB
Bynder
Universiteit Utrecht
Nedap
VDL
Gasunie
Fugro
Unit4
Zeeman
Basic-Fit

The problem: your timeline is not yours

We realised 0.5 billion in public funding for our customers in 2025, and that capital sat outside the equity round, the debt facility and the state of the market.

Growth plans rest on factors the leadership team does not control. Capital gets repriced, regulation changes the calculation mid-project.

Geopolitics moves the things a business depends on, from demand through to the raw materials, components and supply chains that keep it running.

Rarely is the result that a project is dropped outright. More often it is scaled back, delayed or phased in stages until the advantage erodes.

Growth spending is cut first: R&D, expansion and decarbonisation. Not because the investment was wrong, but because it was the line item with no independent source of capital behind it.

Why public funding behaves differently

It attaches to innovation, investment and transformation risk your company already carries.

It follows different logic from private capital or short-term budget cycles. Grants do not have to be repaid and cost no equity.

It is also set against multi-year programme budgets rather than quarterly sentiment, which is what makes it possible to plan around in the first place.

Used deliberately, it is the one source of growth capital that stays steady when the others move against you, which is why resilience is really a question of capital structure.

Three situations where this makes the difference

Companies that stay ahead of their market tend not to guess their way through changing funding programmes. They treat public capital as a normal part of the financial plan, mapped a few years ahead and matched deliberately to the roadmap.

That is what strategic resilience means here. Not a grant won opportunistically once a year, but a forecastable, non-dilutive layer in your capital structure that funds growth while reducing your exposure to the conditions you cannot control.

01

Development is running, capital is tight

You keep developing, but the funds compete with day-to-day operations. Every delay pushes back market entry.

A tax-based instrument works most reliably here, because it runs independently of submission windows and budget pots.

Germany. The Forschungszulage recovers part of eligible R&D expenditure through tax: 25 percent of the eligible base, up to 35 percent for SMEs.

Netherlands. The WBSO reduces the payroll tax remitted for staff on research and development, so it takes effect monthly and also works without profit.

02

Location and supply chain are up for decision

You are relocating production, building a second source or expanding a site to reduce dependency.

The investment is strategically right but pays back later. What decides it is that the application is in before the project starts.

Germany. GRW funding and suitable regional programmes apply where the site sits in an assisted area and regional economic effects arise.

03

Regulation forces a rebuild

A new requirement demands changes that initially only generate cost. The rebuild is not negotiable, and often neither is the timing.

Ongoing additional cost and one-off investment have to be separated. Each follows a different instrument.

Germany. Carbon contracts for difference cover the ongoing additional cost of low-carbon production. For investment, EEW, GRW or the EU Innovation Fund apply.

The EU Innovation Fund is available in both markets for technologies that substantially reduce greenhouse gas emissions.

The principle is straightforward. When you diversify the capital base, you make the strategy more resilient and protect the growth plan at the same time.

The instruments behind resilience

Resilience is built from real programmes, matched deliberately across three levels of funding. The representative set below covers both frontier innovation and growth-stage investment, so it fits large enterprises and scaling companies alike.

EU funding

Horizon Europe and the EU Innovation Fund finance frontier research and first-of-a-kind deployment, the EIC Accelerator and EUREKA Eurostars support innovative SMEs and smaller companies, and IPCEI aligns cross-border industrial transitions.

National funding

In Germany, carbon contracts for difference underwrite the operating economics of decarbonisation, KfW facilities and GRW finance the capital investment, and the Forschungszulage returns value against R&D spend regardless of profit position. In the Netherlands, the WBSO returns R&D cost through payroll tax, and investment incentives such as EIA and MIA/Vamil apply to qualifying capital expenditure.

Regional funding

Provincial and regional programmes add investment and innovation support that stacks on top of the national and EU layers.

Matched correctly, these instruments turn a single volatile input into a diversified, predictable capital base that funds growth as well as protecting it.

How we work

Funding is specialist work, and the decisions that matter are made by people. Technology runs in the background.

Our consultants know the programmes, the evaluators and the sectors, and that judgement is the core of the work. The technology widens the search, keeps the evidence in order and takes over the repetitive administrative work, which leaves our specialists more time for the customer and for the careful reading of the funding landscape. It does not decide what is eligible or how a case is made. The human factor is the one that carries the result.

01

Map the potential.

We go through your projects and separate what qualifies from what does not.

02

Sequence the funding.

We plan across several years so the financing line becomes plannable.

03

Build the applications.

We write against the evaluation criteria rather than the project description.

04

Protect what is awarded.

We keep documentation and evidence audit-proof throughout the funded period.

We also treat regulatory and market change as a source of opportunity. When a mandate, a transition scheme or an industrial-strategy budget moves, we identify the instruments it opens for you, so you can act while the opportunity is still open.

And we are candid about what fails. We record every outcome, the successes as well as the rejections and the audits, which means we can name the likely failure patterns and repeat what works before a submission rather than explain either afterwards.

What this means for the other roles

An unverified grant is a liability on the balance sheet rather than a gain, and the documentation discipline is what separates forecastable non-dilutive capital from an application that will not hold up under audit. We set up an audit-ready structure from the start of the engagement, so the funding you planned for is the funding you keep.

A funding pipeline should protect the roadmap rather than consume it, so we structure funding around your development pipeline and handle the administrative work ourselves. That keeps your engineers building instead of writing applications.

The people behind your application

LinkedIn

Joost Schreuder

Medior Consultant

LinkedIn

Liesanne Veenstra

Senior Consultant

LinkedIn

Lisan Kooijmans

Senior Consultant

LinkedIn

Maarten Klumpers

Senior Consultant

What sets us apart

500Million

funding realized in 2025

Start your Funding Scan

What makes the difference

Your competitors are already using public funding that you have earned just as much. The difference over time comes down to who plans for it and who leaves it on the table.

Built into the financing structure from the start, rather than chased once a year, public funding becomes a dependable way to finance the next stage of growth and to hold your course when the market does not.

FAQs about funding advisory

View all FAQs

Yes, if funding is treated as a multi-year pipeline rather than application by application. Individual approvals are never guaranteed; a structured portfolio is plannable.

No. Research and development is one part of it. Public funding also supports capital investment, sustainability and the energy transition, digitalisation, expansion and training, and there are programmes designed specifically for small and medium-sized companies as well as for large enterprises. The right mix depends on what you are building, not on your size.

Yes, and it often matters more at that stage. Non-dilutive funding extends runway and finances the next step without another equity round, and several instruments, including the tax-based R&D instruments and SME innovation grants, are built with smaller and pre-profit companies in mind.

Grants generally not, as long as the conditions are met. Clawback arises mainly from breaches of conditions, ineligible costs or incomplete evidence.

Not with grants. It is different with instruments that include an equity component, such as certain European programmes, where that is decided before the application.

It depends on the programmes you qualify for and the rules that apply when they are combined. Rather than promise a headline figure, we map the eligible schemes, model what they return when stacked, and give you a realistic number before you commit any of your team’s time.

That depends on the instrument. Grants are paid after approval and drawdown, tax-based instruments take effect through the tax assessment, loans through the terms.

Yes. Much of the value comes from stacking EU, national and regional programmes so they reinforce rather than clash, and from coordinating across the markets you operate in. With specialists in both markets and across Europe, that cross-border view is part of how we plan.

As little as possible. We ask your people for the detail only they can give, usually in a few focused sessions, and we handle the identification, the applications, the documentation and the reporting ourselves. The aim is to fund the strategy without turning it into an administrative project.

Coverage and specialisation. We track thousands of programmes across Europe, we plan the funding as a forecastable part of your capital structure rather than a series of one-off applications, and we manage the full lifecycle from eligibility through audit. That combination tends to find and protect more than an internal team can while also running the business.